UFMylation Modulates OFIP Stability and Centrosomal Localization
Journal of Clinical Laboratory Analysis · 2025-03 · 39 (6)
DOI: 10.1002/jcla.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 10.03.2025. Verfasst von Mulin Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Cell Biology, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, Ch…. Hauptthemen laut MEDLINE: Centrosome, Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Nature Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
OFIP, also known as KIAA0753, is a centrosomal and pericentriolar satellite protein implicated in ciliogenesis, centriolar duplication, and microtubule stability. In humans, genetic mutations affecting OFIP have been implicated in the pathogenesis of Oral‐Facial‐Digital (OFD) Syndrome and Joubert Syndrome. Ubiquitin‐fold Modifier 1 (UFM1), the most recently identified ubiquitin‐like protein, is covalently transferred to its substrates, in a process known as UFMylation. This modification has recently emerged as a key regulator of various biological processes by altering their stability, activity, or localization.
Methods
The interaction between UFL1 and OFIP, as well as the UFMylation of OFIP, were assessed through immunoprecipitation and immunoblotting analyses. The mRNA levels of OFIP were examined using reverse transcription quantitative PCR (RT‐qPCR). Immunofluorescence microscopy was employed to examine the localization and distribution patterns of OFIP.
Results
Our findings demonstrate that UFL1 interacts with OFIP both in vivo and in vitro. We also found that OFIP undergoes UFMylation, and UFL1 promotes the OFIP UFMylation. Mechanistic studies demonstrate that OFIP UFMylation inhibits its protein stability and maintains its proper centrosomal localization. However, the efficacy of these regulatory mechanisms varies significantly between different cell types, being notably pronounced in HeLa cells but markedly reduced in RPE1 cells.
Conclusions
OFIP is identified as a novel substrate for UFMylation. UFL1‐mediated OFIP UFMylation is essential for its stability and centrosomal localization in HeLa cells. However, these effects are not observed in RPE1 cells, highlighting cell type‐specific heterogeneity in the role of OFIP UFMylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Cell Biology, College of Life Sciences, State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
- Center for Cell Structure and Function, Shandong Provincial Key Laboratory of Animal Resistance Biology, College of Life Sciences, Shandong Normal University, Jinan, China.
ORCID-Profile: Jie Ran
Förderung
- National Nature Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Yang, M., Zhao, Z., Di, J., Dong, D., Li, D., & Ran, J. (2025). UFMylation Modulates OFIP Stability and Centrosomal Localization. Journal of Clinical Laboratory Analysis, 39(6). https://doi.org/10.1002/jcla.70004
Vancouver
Yang M, Zhao Z, Di J, Dong D, Li D, Ran J. UFMylation Modulates OFIP Stability and Centrosomal Localization. Journal of Clinical Laboratory Analysis. 2025;39(6). doi:10.1002/jcla.70004
BibTeX
@article{Yang2025,
author = {Yang, Mulin and Zhao, Zihe and Di, Jie and Dong, Dan and Li, Dengwen and Ran, Jie},
title = {UFMylation Modulates OFIP Stability and Centrosomal Localization},
journal = {Journal of Clinical Laboratory Analysis},
year = {2025},
volume = {39},
number = {6},
doi = {10.1002/jcla.70004}
}
EUVIMED